Abstract:Background & aims: Autoimmune hepatitis (AIH) is characterized by hepatocyte destruction, leading to lymphocyte and macrophage accumulation in the liver. However, the specific mechanisms of how macrophages participate in the occurrence and development of AIH are still unclear. In this study, we investigated the effect of monocyte-derived macrophages on Con A-induced immunological liver injury in mice and we hypothesized that inhibition of CCR2 with the dual CCR2/5 inhibitor, cenicriviroc (CVC), would attenuate Con A-induced hepatitis in mice by reducing the recruitment of monocytes into the liver. Methods: Murine experimental AIH was established by concanavalin A (Con A) injection intravenously. Macrophages were depleted by injection of clodronate liposomes in Con A-treated mice. Moreover, inhibition of the CCR2/5 signaling pathway in Con A mice is achieved by CVC. Liver injury and infiltration of monocyte-derived macrophages were assessed by serum transaminase levels, histopathology, immunohistochemistry, flow cytometry, RT-qPCR, ELISA, TUNEL assay and dihydroethidium staining. Results: The number of macrophages in the mouse livers increased in the Con A-induced hepatitis mouse model, and flow cytometry showed a significant increase in the proportion of F4/80loCD11bhi monocyte-derived macrophages, while there was no significant change in the proportion of F4/80hiCD11blo Kupffer cells. After the depletion of liver macrophages by clodronate liposomes, the levels of serum ALT and AST, and the degree of liver tissue damage were alleviated in Con A-treated mice. Furthermore, Con A leaded an increase in the expression of a group of CC chemokines in mouse livers, and the elevation of CCL2 was prevented with the depletion of macrophages. Additionally, CVC reduced macrophage infiltration in the liver and ameliorated Con A-induced liver injury. Meanwhile, CVC reduced the apoptosis and oxidative damage of hepatocytes caused by Con A. Conclusions: Our research demonstrates that there is an increase in monocyte-derived macrophages in the livers due to the monocyte infiltration resulted from the activation of the CCL2-CCR2 axis in Con A-induced liver injury mouse model. Pharmacological inhibition of CCR2 monocyte recruitment by CVC efficiently ameliorates the hepatic inflammation, indicating the therapeutic potential of CVC in patients with AIH.

Recent advances targeting C‐C chemokine receptor type 2 for liver diseases in monocyte/macrophage

Recent Advances Targeting C‐C Chemokine Receptor Type 2 for Liver Diseases in Monocyte/macrophage

Emerging Importance of Chemokine Receptor CXCR4 and Its Ligand in Liver Disease

Functional Roles of Chemokine Receptor CCR2 and Its Ligands in Liver Disease

Regulation and functional roles of chemokines in liver diseases

The Roles of C-C motif Chemokine Ligand 2(CCL2) in Liver Diseases

Functional Roles of CCL5/RANTES in Liver Disease

Targeting hepatic macrophages for non-alcoholic fatty liver disease therapy

Targeting of Tumour-Infiltrating Macrophages Via CCL2/CCR2 Signalling As a Therapeutic Strategy Against Hepatocellular Carcinoma

Modification of Chemokine Pathways and Immune Cell Infiltration as a Novel Therapeutic Approach in Liver Inflammation and Fibrosis

Function and Therapeutic Advances of Chemokine and Its Receptor in Nonalcoholic Fatty Liver Disease

Monocyte-derived macrophages contribute to the deterioration of immunological liver injury in mice

Neutrophil subsets in noncancer liver diseases: Cellular crosstalk and therapeutic targets

An Update on the Chemokine System in the Development of NAFLD

Expression of Chemokine Receptors on Intrahepatic and Peripheral Lymphocytes in Chronic Hepatitis C Infection: Its Relationship to Liver Inflammation.

The Critical Role of Chemokine (C-C Motif) Receptor 2-Positive Monocytes in Autoimmune Cholangitis

Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis

Liver Macrophages: Old Dogmas and New Insights

Uncovering key molecules and immune landscape in cholestatic liver injury: implications for pathogenesis and drug therapy

Chemokines in Chronic Liver Allograft Dysfunction Pathogenesis and Potential Therapeutic Targets

The role of macrophage-derived exosomes in noncancer liver diseases: From intercellular crosstalk to clinical potential